Bridged 5,6,7,8-tetrahydro-1,6-naphthyridines, analogues of huperzine A: Synthesis, modelling studies and evaluation as inhibitors of acetylcholinesterase

European Journal of Organic Chemistry

Volumn , Issue 5, 2009, Pages 643-654

  Vanlaer, Sofie ^a   Voet, Arnout ^a   Gielens, Constant ^a   De Maeyer, Marc ^a   Compernolle, Frans ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Acetylcholinesterase; Inhibitors; Nucleophilic substitution; Pyridines; Ring closing metathesis; Tetrahydro 1,6 naphthyridines

Indexed keywords

EID: 60849091910     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200800972     Document Type: Article

References (31)

1. X. Ma, C. Tan, D. Zhu, D. R. Gang, J. Ethnopharmacol. 2006, 104,54-67.
2. T. Wang, X. C. Tang, Eur. J. Pharmacol. 1998, 349, 137-142;
3. Y. E. Wang, D. X. Yue, X. C. Tang, Acta Pharmacol. Sin. 1986, 7, 110-113;
4. Q. Zhao, X. C. Tang, Eur. J. Pharmacol. 2002, 455, 101-107.
5. Y. E. Wang, D. X. Yue, X. C. Tang, Acta Pharmacol. Sin. 1986, 7, 110-113;
6. D. H. Cheng, H. Ren, X. C. Tang, Neuroreport 1996, 8,97-101.
7. R. Wang, H. Y. Zhang, X. C. Tang, Eur. J. Pharmacol. 2001, 21, 149-156;
8. X. Q. Xiao, R. Wang, Y. F. Hang, X. C. Tang, Neurosci. Lett. 2000, 286, 155-158;
9. J. Zhou, Y. Fu, X. C. Tang, Neurosci. Lett. 2001, 306,53-56.
10. A. P. Kozikowski, W. Tückmantel, Acc. Chem. Res. 1999, 32, 641 -650;
11. Y. Xia, A. P. Kozokowski, J. Am. Chem. Soc. 1989, 111, 4116-4117;
12. A. P. Kozokowski, Y. Xia, E. R. Reddy, J. Org. Chem. 1991, 56, 4636-4645.
13. A. P. Kozikowski, W. Ti ckmantel, Acc. Chem. Res. 1999, 32, 641 -650;
14. G. Zhou, D. Zhu, Bioorg. Med. Chem. Lett. 2000, 10, 2055-2057;
15. K. Högenauer, K. Baumann, A. Enz, J. Mulzer, Bioorg. Med. Chem. Lett. 2001, 11, 2627-2630.
16. P. Camps, D. Muñoz-Torrero, Mini-Rev. Med. Chem. 2001, 1, 163-174;
17. P. Camps, J. Contreras, M. Font-Bardia, J. Morral, D. Muñoz-Torrero, X. Solans, Tetrahedron: Asymmetry 1998, 9, 835-849;
18. A. Badia, J. E. Banos, P. Camps, J. Contreras, D.M. Görbig, D. Muñoz-Torrero, M. Simon, N. M. Vivas, Bi-oorg. Med. Chem. 1998, 6, 427-440.
19. H. Dvir, D. M. Wong, M. Harel, X. Barril, M. Orozco, F. J. Luque, D. Munoz-Torrero, P. Camps, T. L. Rosenberry, I. Sil-man, J. L. Sussman, Biochemistry 2002, 41, 2970-2981.
20. S. Vanlaer, W. M. De Borggraeve, A. Voet, C. Gielens, M. De Maeyer, F. Compernolle, Eur. J. Org. Chem. 2008, 2571 -2581.
21. M. J. Martinelli, N. K. Nayyar, E. D. Moher, U. P. Dhokte, J. M. Pawlak, R. Vaidyanathan, Org. Lett. 1999, 1, 447-450;
22. M. J. Martinelli, R. Vaidyanathan, Tetrahedron Lett. 2000, 41, 3733-3776.
23. S. K. Taylor, N. H. Chmiel, E. E. Mann, M. E. Silver, J. R. Vy-vyan, Synthesis 1998, 1009-1014;
24. T. J. Strurm, A. E. Marolew-ski, D. S. Rezenka, S. K. Taylor, J. Org. Chem. 1989, 54, 2039-2040;
25. S. K. Taylor, J. A. Fried, Y. N. Grassl, A. E. Marolewski, E.A. Pelton, T. J. Poel, D. S. Rezenka, M. R. Whittakern, J. Org. Chem. 1993, 58, 7304-7305.
26. D. G. Hawthorne, S. R. Johns, R. I. Willing, Aust. J. Chem. 1976, 29, 315-326.
27. A. Fürstner, K. Langemann, J. Am. Chem. Soc. 1997, 119, 9130-9136.
28. S. Brass, H. D. Gerber, S. Doerr, W. E. Diederich, Tetrahedron 2006, 62, 1777-1786.
29. G. L. Ellman, K. D. Courtney, V. Andres, R. M. Featherstone, Biochem. Pharmacol. 1961, 7,88-95.
30. P. Camps, B. Cusack, W. D. Mallender, R. El Achab, J. Morral, D. Muñoz-Torrero, T. R. Rosenberry, Mol. Pharmacol. 2000, 57, 409-417.
31. MOE (The Molecular Operating Environment), version 2005.06, software available from Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal, Canada H3A 2R7 (http://www.chemcomp.com).